"10.1371_journal.pone.0024422","plos one","2011-09-14T00:00:00Z","Gabrielle Fredman; Sungwhan F Oh; Srinivas Ayilavarapu; Hatice Hasturk; Charles N Serhan; Thomas E Van Dyke","Department of Periodontology, The Forsyth Institute, Cambridge, Massachusetts, United States of America; Department of Anesthesiology, Perioperative, and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital Harvard Medical School, Boston, Massachusetts, United States of America","Conceived and designed the experiments: GF TEVD. Performed the experiments: GF SFO SA. Analyzed the data: GF SFO SA HH CNS TEVD. Contributed reagents/materials/analysis tools: GF SFO SA HH CNS TEVD. Wrote the paper: GF TEVD.","The authors have read the journal's policy and have the following conflicts: C.N.S. is an inventor on patents assigned to Brigham and Women's Hospital on the resolvins, related compounds, and their analogs and uses (C.N.S. and T.E.V.D.) that are licensed for clinical development. There are several patents, details of which can be provided on request. C.N.S. and T.E.V.D. retain founder stock in Resolvyx Pharmaceuticals. There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2011","09","Gabrielle Fredman","GF",6,TRUE,2,3,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
